Seres Therapeutics Inc (NASDAQ: MCRB): Reassessing Prospects
Seres Therapeutics Inc (MCRB) concluded trading on Wednesday at a closing price of $1.02, with 3.69 million shares of worth about $3.76 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -76.22% during that period and on Wednesday February 7 the price saw a […]
Technical Outlook And Game Plan For Seres Therapeutics Inc (NASDAQ: MCRB)
Fidelity Management & Research Co has recently announced that it has increased stake in Seres Therapeutics Inc (NASDAQ:MCRB) by 0.24%. After grabbing 19.23 million shares, the institutional investor is now in possession of 45484.0 shares of the Healthcare Company. The new investment brought the stake of investor firm to 14.88% having worth around $26.92 million. […]
Seres Therapeutics Inc (NASDAQ: MCRB) Has Another Chance To Impress You
Fidelity Management & Research Co recently announced the acquisition of new stake in Seres Therapeutics Inc (NASDAQ:MCRB). The institutional investor has increased its shareholding in the Healthcare company by 0.24% to 19.23 million shares with purchase of 45484.0 shares. This fresh investment now brings its stake to 14.88% valued currently at $20.0 million. In addition, […]
Investors Should Take Note Of Seres Therapeutics Inc (MCRB)
Fidelity Management & Research Co has recently announced that it has increased stake in Seres Therapeutics Inc (NASDAQ:MCRB) by 0.24%. After grabbing 19.23 million shares, the institutional investor is now in possession of 45484.0 shares of the Healthcare Company. The new investment brought the stake of investor firm to 14.88% having worth around $20.0 million. […]
Seres Therapeutics Inc (NASDAQ: MCRB) Is Getting Increasingly Hard To Ignore
Fidelity Management & Research Co recently announced the acquisition of new stake in Seres Therapeutics Inc (NASDAQ:MCRB). The institutional investor has increased its shareholding in the Healthcare company by 0.24% to 19.23 million shares with purchase of 45484.0 shares. This fresh investment now brings its stake to 14.88% valued currently at $20.0 million. In addition, […]
Is Seres Therapeutics Inc (NASDAQ: MCRB) Back In The Buying Zone?
Fidelity Management & Research Co recently announced the acquisition of new stake in Seres Therapeutics Inc (NASDAQ:MCRB). The institutional investor has increased its shareholding in the Healthcare company by 0.24% to 19.23 million shares with purchase of 45484.0 shares. This fresh investment now brings its stake to 15.00% valued currently at $29.42 million. In addition, […]
Seres Therapeutics Inc (NASDAQ: MCRB) – Not A Clear Buying Opportunity?
Fidelity Management & Research Co has recently announced that it has increased stake in Seres Therapeutics Inc (NASDAQ:MCRB) by 0.24%. After grabbing 19.23 million shares, the institutional investor is now in possession of 45484.0 shares of the Healthcare Company. The new investment brought the stake of investor firm to 15.00% having worth around $29.42 million. […]
Growing Through Challenges? – Seres Therapeutics Inc (MCRB)
Fidelity Management & Research Co recently announced the acquisition of new stake in Seres Therapeutics Inc (NASDAQ:MCRB). The institutional investor has increased its shareholding in the Healthcare company by 0.24% to 19.23 million shares with purchase of 45484.0 shares. This fresh investment now brings its stake to 15.00% valued currently at $29.42 million. In addition, […]
